Treatment of Elderly Patients with CLL: Does Bendamustine Replace Chlorambucil as “Standard of Care”? 2. Juni 2013 Knauf, W., Abenhardt, W., Nusch, A., Grugel, R., Marschner, N., 2013. Hematol Oncol 31 (Suppl. I)(Abstract 372), 219. doi:10.1002/hon.2059 Abstract VMP in 1st-Line Treatment of Non-Transplant Patients with Multiple Myeloma in Routine Practice: First Follow-Up Data from the Tumour Registry Lymphatic Neoplasms. Knauf, W., Abenhardt, W., Harich, H.-D., Schlag, R., Grugel, R., Marschner, N., 2013. Onkologie 36 (suppl 7)(P528), 152–153. doi:10.1159/000356365 Abstract… Weiterlesen Treatment of indolent NHL by office-based haematologists in Germany: R-bendmustine replaces R-CHOP as “Standard of Care.” Knauf, W., Abenhardt, W., Nusch, A., Grugel, R., Marschner, N., 2013. Hematol Oncol 31 (Suppl. I)(Abstract 467), 248. doi:10.1002/hon.2059 Abstract… Weiterlesen